Muscle relaxants Flashcards

1
Q

Why might we need muscle relaxation?

A
  • to offset muscle hypertonicity with ketamine (increases muscle tone as induction agent)- can use BZPs, alpha 2s
  • to relieve muscle spams (BZPs)–>pulled muscle
  • to facilitate smooth induction of anaesthesia in large animals (GGE)–> centrally acting
  • to improve surgical conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do we produce adequate muscle relaxation for surgery

A
  • deep general anaesthesia: induction and maintenance provide muscle relaxation- nb: profound CV depression

Local anaesthesia: can inject LA around motor nerve, muscle will relax i.e. epidural anaesthesia

Centrally acting muscle relaxants: BZPs– provide SOME muscle relaxation- centrally, not locally acting. high doses to get good muscle relaxation (side effect=respiratory depression)

Neuromuscular blocking drugs: prevent transmission at neuromuscular junction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Curare

A

naturally occuring muscle relaxant

not absorbed GI, don’t work orally (polar molecules)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mechanism of action of Neuromuscular blocking drugs (NMBs/NMBDs)

A

target Nicotinic ACh receptor at neuromuscular junction

Signal tranmission: action potential–> calcium release pre-synaptically–>exocytosis of ACh–>activated ACh receptors open ion channels–> NA+ influx into muscle–> EPP–>AP–>contraction

ACh broken down by acetylcholinesterase– terminates action, rapidly brings ACH back into nerve terminal

NMBs: depolarizing or non-depolarizing action at post-synapstic cell. Agonists or antagonists at receptors

NB: ANTIcholinesterases block acetylcholinesterases. Can use anticholinesterase to reverse non-polarizing drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NMBs work by interfering with post-synaptic action of ACh

A

non-depolarising: tubocurarine, gallamine, pancuronium, vercuronium, atracurium, rocuronium

depolarising: suxamethonium- not widely used in vet med

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-depolarizing NMBs-Mechanism of action

A

Competitive antagonist at the nicotinic ACh receptor. Reversible! Block transmission from ACh from binding.

rigid, bulky molecules with quarternary N (polar, charged)- won’t cross cellular membranes, won’t distribute very far in body

Need to block ~80% of receptor sites- muscle tissue have receptor reserve. to block system, need to block a high proportion of receptors

Transmission is “all or nothing”- muscle either contracts or doesn’t. The varying degree of block relates to the proportion of fibres

Some may block ion channels: at higher concentrations

Reversed by anticholinesterases (if you increase the presence of ACh, can overcome block)

Muscles can still respond to K+ or direct electrical stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Non-depolarizing NMBs: effects and side effects

A

Effects: flaccid motor paralysis- rapidly moving muscles see 1st effects

respiratory muscles last to be effected and first to recover

NB: consciousness and perception of pain are normal- no analgesic propertises. should be used as part of analgesic/anaesthetic protocol

Unwanted effects: fall in BP: ganglion block/histamine release– targeting nicotinic receptors–> N receptors at sympatetic ganglia–>fall in BP

tachycardia: muscarinic receptor block- not totally specific for nicotinic, can bind to muscarinig receptors–> decrease PS–> tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmacokinetics of NMBS

A

mostly quaternary ammonium compounds (some steroid base)

Administered IV only- Vd ~ ECF, not highly plasma protein bound

Rate of onset and duration vary

generally metabolized by the liver or can be excreted unchanged by the kidney

Don’t cross BBB (due to physical structure) or placenta (safe to use in c-section)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Two main groups of non-depolarizing NMBs

A

aminosteroids (suffix “onium”): vecruonium, rocuronium, pancuronium

Benzylisoquinolines: most likely to release histamine (more of a problem in humans)

atracurium, cisatracurium, mivacurium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vecuronium

A

aminosteroid non-depolarizing NMB

steroid compound

devoid of CV side-effects: most cardiostable of all muscle relaxants- no drops in CO or BP, choose for cardiac disease

excreted unchanged in bile- prolonged duration of action in severe hepatic disease (avoid if liver disease)

non-cumulative: short acting, topped up as necessary, can give as infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rocuronium

A

aminosteroid non-depolarizing NMB

fastest onset of any non-depolarizing agent (<2 minute)

occasional tachycardia in dogs

non-cummulative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Atracurium

A

benzylisoquinolone

can release histamine (uncommon in animals)

Hoffmann elimination: spontaneous degradation at physiological pH and temperature. Not dependent on organ for elimination- choose this if we have patient with hepatic disease. No prolonged duration due to spontaneous breakdown in plasma.

must be stored in fridge.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Relaxants- practical use

A

relaxants ONLY administered IV

they will induce apnea, so patient must be mechanically ventilated

they are only administered to anaesthetized patients- can’t control ventilation in conscious patient

no anaesthetic or analgesic effects

non-depolarizing NMBs can be “topped up” or given by infusion IV for as long as required.

if you give a clinically sufficient dose, ALL muscles affected (just at different rates). Diaphgram and IC mm are most resistant and last to become affected and first to start working again. Muscles of pharyngeal area highly sensitive, eye becomes centrally fixed.

possible for patient to start breathing again as relaxant effects wears off, but not able to maintain patent airway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Choosing a relaxant

A

NB: not relaxants licensed for animal use

Pre-existing pathology: cardiostability (vecuronium); renal /hepatic disease (atracurium); rapid onset (rocuronium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Depolarizing NMBs

A

Mechanism of action: agonist at nicotinic ACh repector, but metabolised slowly. ACh normally rapidly cleared from synapsed. Depolarizing NMB slowly metabolised–>persistence of action–>rapid loss of muscle control–> muscle relaxes.

Flexible structure with free bond rotation- doesn’t block, but interacts with receptor as agonist.

enhanced by anticholinesterases- can’t be reversed in the same way as non-depolarizing NMBs

leads to loss of electrical excitability of muscle cells

no longer respons to K+ or electrical stimulation

Effects: initial fasciculation- twitching/trembling–> individual muscle fibres contracting

subsides as electrical excitability is lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Phases of depolarizing NMBs

A

Phase 1: depolarizing, fasciculations, presence of agonist prevents repolarization–> muscle can’t contract

Phase 2: desensitizing- depolarizing shouldn’t be given by bolus or by infusion–> only should be used for short term effects. Ion channels in a prolonged closed state. could be due to channel block or development of unexcitable tissue.

17
Q

Depolarizing NMBs side effects

A

non-selective agonist–> can also stimulate muscarinic receptors

bradycardia

potassium release due to prolonged opening of channels–> can cause heart issues

increased intra-ocular pressure due to constriction of muscles surrounding eye

prolonged paralysis: normally 5-20 minutes but can get prolonged (i.e. with use in anticholinesterases) some individuals who lack enzyme to break down these drugs; hepatic impairment can also results in this prolonged paralysis

Malignant hyperthermia

18
Q

Suxamethonium (succinylcholine)

A

depolarizing NMBs- v. limited use in vet med

Rapid onset: <1 min

popular in humans for ET tubes

short duration: 3-6 minutes in cats; 15-20 minutes in dogs (not sued in dogs)

Metabolised by plasma and liver cholinesterase- produced by liver- in hepatic disease–> long duration of action.

only used as a single dose

only real indication is feline ET intubtion- when we need to get ET tube in quickly

cat has v. sensitive larynx, can spasm, normally spray LA but that takes a couple minutes.

If we have a cat with a full stomach that needs to be intubated for emergency surgery, a couple minutes is too long–> can use suxamethonium.

19
Q

Comparison of depolarizing vs. non-depolarizing NMBs

A

Suxamethonium: initial muscle fasciculation prior to relaxtion, can’t be topped up, can’t be antagonized

Non-depolarizing NMBs: no initial fasciculations, can be topped up as required, can be antagonized.

20
Q

Indications for use of NMBs

A

to faciliate ET intubation

to relax skeletal muscle for easier surgical access- i.e. deep dissections of abdomen

to control ventilation during anaesthesia- i.e. during cardiac surgery

ophthalmic surgery: central paralysis of extraocular muscles

21
Q

Recovery of neuromuscular blockade

A

will occur spontaneously

as plasma concentration of relaxant declines, drug will move down it’s concentration gradient from NMJ into plasma. Eventually, sufficient relaxant will have left to restore NM transmission.

Can be hastened with NON-depolarizing relaxants only by administering ANTIcholinesterases

Non-depolarizing relaxants are competitive: if ACh concentrations increase to a sufficient level at the NMJ, tranmission will be restored. ACh is broken down by acetylcholinesterases, so if this enzyme is inhibited by anticholinesterase, ACh levels will increase.

22
Q

Anticholinesterases

A

neostigmine and edrophonium (common)

pyridostigmine

only effective against NON-depolarizing relaxants

ACh concentrations increase not olny at the NMJ but throughout the body

Action of ACh at muscarinic receptors–> parasympathetic side effects–> bradycardia, salivation, bronchoconstriction, urination and defecation

As a result of these muscarinic effects, usually combined with antimuscarinic/anticholinergic drugs: atropine or glycopyrrolate.

23
Q

Sugammadex

A

novel antagonist to rocuronium/vecuronium

cyclodextrin molecule

surrounds relaxant, rendering it inactive

no antimuscarinic needed- no side effects.

expensive

24
Q

Factors affecting NM blockade

A

Other drugs: anaesthetics, anticholinesterases, ABX- some aminoglycosides prolong some fx on non-depolarizing NMBs- horses: gentamycin can prolong muscle relaxant effect.

Pathophysiological conditions: hepatic/renal impairment, age (very old, very young get prolonged effect), temperature, acid-base balance, electrolyte disturbance, myasthenia gravis- auto-immune antibodies against ACh receptor. very prolonged side effects fom non-depolarizing agents.

25
Q

Centrally acting muscle relaxants

A

BZPs and Guaifenesin

26
Q

Guaifenesin

A

=glycerol gualacolate or “Gee gee”, GGE

mechanism of action: blocks impulse transmission at internuncial neurones within spinal cord and brain stem

Effects: relaxes limbs more than respiratory muscles

mild sedation, but no analgesia

uses: smooth induction of anaesthesia in horses and cattle (not licensed in cattle).

Cattle sensitive to hemolysis with GGE solutions, so usually used as a homemade 5% solution in cattle.

Administer via IV catheeter until animal shows signs of ataxia, followed by IV anaesthetic agent

NB: irritnant, therefore need iV catheter.

often: alpha 2, then GGE, then IV induction agent.